Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Xie

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine]Xu Wei, Zhanjun Zhang, Yanming Xie, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine]Yan Zhuang, Bangtie Xie, Shengxin Weng, et al.
Frontiers in Pharmacology|July 28, 2020
Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE AssessmentJian Lyu, Yanming Xie, Menghua Sun, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials]Yanming Xie, Yanping Wang, Feng Tian, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Study on method on post-marketing traditonal Chinese medicine safety assessment]Qiuai Kou, Suping Zhao, Guoshuang Feng, et al.
Journal of Ethnopharmacology|July 30, 2020
Clinical evidence and GRADE assessment for breviscapine injection (DengZhanHuaSu) in patients with acute cerebral infarctionJian Lyu, Yanming Xie, Menghua Sun, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|November 25, 2014
Establishment of safety evidence for Xingxue Shuxuening injectionWei Yang, Wen Zhang, Yanming Xie, et al.
Journal of Ethnopharmacology|November 20, 2021
Xuesaitong oral preparation as adjuvant therapy for treating acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trialsHongjiao Geng, Lidan Zhang, Cui Xin, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 7, 2015
Postmarketing evaluation on the safety and effectiveness of deng-zhanxixin injection made from Dengzhanxixin (Herba Erigerontis Breviscapi)Yuanyuan Li, Gufeng Lin, Yanming Xie, et al.
Plos One|February 24, 2015
Trends in the use of guideline-recommended medications and in-hospital mortality of patients with acute myocardial infarction in a Chinese populationJing Hu, Yanming Xie, Zheng Shu, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine]Xu Wei, Zhanjun Zhang, Yanming Xie, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine]Yan Zhuang, Bangtie Xie, Shengxin Weng, et al.
Frontiers in Pharmacology|July 28, 2020
Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE AssessmentJian Lyu, Yanming Xie, Menghua Sun, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials]Yanming Xie, Yanping Wang, Feng Tian, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Study on method on post-marketing traditonal Chinese medicine safety assessment]Qiuai Kou, Suping Zhao, Guoshuang Feng, et al.
Journal of Ethnopharmacology|July 30, 2020
Clinical evidence and GRADE assessment for breviscapine injection (DengZhanHuaSu) in patients with acute cerebral infarctionJian Lyu, Yanming Xie, Menghua Sun, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|November 25, 2014
Establishment of safety evidence for Xingxue Shuxuening injectionWei Yang, Wen Zhang, Yanming Xie, et al.
Journal of Ethnopharmacology|November 20, 2021
Xuesaitong oral preparation as adjuvant therapy for treating acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trialsHongjiao Geng, Lidan Zhang, Cui Xin, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 7, 2015
Postmarketing evaluation on the safety and effectiveness of deng-zhanxixin injection made from Dengzhanxixin (Herba Erigerontis Breviscapi)Yuanyuan Li, Gufeng Lin, Yanming Xie, et al.
Plos One|February 24, 2015
Trends in the use of guideline-recommended medications and in-hospital mortality of patients with acute myocardial infarction in a Chinese populationJing Hu, Yanming Xie, Zheng Shu, et al.
Pageof 13